These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
208 related articles for article (PubMed ID: 32236926)
1. [Sequential Natriuretic Peptide Measurements to Monitor Treatment and Prognosis During Heart Failure Therapy]. Becher MU Dtsch Med Wochenschr; 2020 Apr; 145(7):458-463. PubMed ID: 32236926 [TBL] [Abstract][Full Text] [Related]
2. [Expert consensus on the usefulness of natriuretic peptides in heart failure.]. Nessler J; Straburzyńska-Migaj E; Windak A; Solnica B; Szmitkowski M; Paradowski M; Kaźmierczak J; Puacz E; Rozentryt P Kardiol Pol; 2018; 76(1):215-224. PubMed ID: 29399772 [TBL] [Abstract][Full Text] [Related]
3. [Natriuretic peptides for the management of patients with heart failure: a bridge between primary care and cardiology?]. D'Ambrosio G; Parretti D; De Maria R; Cricelli I; Di Tano G; Aspromonte N G Ital Cardiol (Rome); 2016 Jan; 17(1):41-7. PubMed ID: 26901257 [TBL] [Abstract][Full Text] [Related]
4. A Test in Context: Critical Evaluation of Natriuretic Peptide Testing in Heart Failure. Francis GS; Felker GM; Tang WH J Am Coll Cardiol; 2016 Jan; 67(3):330-7. PubMed ID: 26796399 [TBL] [Abstract][Full Text] [Related]
5. Targeting Natriuretic Peptide Levels in Heart Failure with Therapy: Does "X" Really Mark the Spot? Logan JK; Mentz RJ Curr Heart Fail Rep; 2019 Dec; 16(6):250-256. PubMed ID: 31741230 [TBL] [Abstract][Full Text] [Related]
6. Does natriuretic peptide monitoring improve outcomes in heart failure patients? A systematic review and meta-analysis. Khan MS; Siddiqi TJ; Usman MS; Sreenivasan J; Fugar S; Riaz H; Murad MH; Mookadam F; Figueredo VM Int J Cardiol; 2018 Jul; 263():80-87. PubMed ID: 29685696 [TBL] [Abstract][Full Text] [Related]
7. Evolution of natriuretic peptide biomarkers in heart failure: Implications for clinical care and clinical trials. Vodovar N; Mebazaa A; Januzzi JL; Murtagh G; Stough WG; Adams KF; Zannad F Int J Cardiol; 2018 Mar; 254():215-221. PubMed ID: 29407093 [TBL] [Abstract][Full Text] [Related]
8. Multiple biomarker strategy based on parathyroid hormone and natriuretic peptides testing for improved prognosis of chronic heart failure. Gruson D; Ahn SA; Rousseau MF Peptides; 2015 Feb; 64():24-8. PubMed ID: 25572303 [TBL] [Abstract][Full Text] [Related]
9. Clinical Applications of Natriuretic Peptides in Heart Failure and Atrial Fibrillation. Baba M; Yoshida K; Ieda M Int J Mol Sci; 2019 Jun; 20(11):. PubMed ID: 31185605 [TBL] [Abstract][Full Text] [Related]
10. The role of natriuretic peptides as biomarkers for guiding the management of chronic heart failure. Motiwala SR; Januzzi JL Clin Pharmacol Ther; 2013 Jan; 93(1):57-67. PubMed ID: 23187878 [TBL] [Abstract][Full Text] [Related]
12. The potential role of natriuretic peptide-guided management for patients hospitalized for heart failure. Maisel A; Xue Y; Greene SJ; Pang PS; Januzzi JL; Piña IL; DeFilippi C; Butler J J Card Fail; 2015 Mar; 21(3):233-9. PubMed ID: 25433362 [TBL] [Abstract][Full Text] [Related]
13. Prognostic value of combining echocardiography and natriuretic peptide levels in patients with heart failure. Yin WH; Chen JW; Lin SJ Curr Heart Fail Rep; 2012 Jun; 9(2):148-53. PubMed ID: 22351121 [TBL] [Abstract][Full Text] [Related]
14. Natriuretic peptides as biomarkers of cardiac endocrine function in heart failure: new challenges and perspectives. Clerico A; Passino C; Franzini M; Emdin M Future Cardiol; 2016 Sep; 12(5):573-84. PubMed ID: 27459871 [TBL] [Abstract][Full Text] [Related]
16. Natriuretic peptides in heart failure: where we are, where we are going. Palazzuoli A; Antonelli G; Quatrini I; Nuti R Intern Emerg Med; 2011 Feb; 6(1):63-8. PubMed ID: 20853071 [TBL] [Abstract][Full Text] [Related]
17. [Diagnosis of acute heart failure and relevance of biomarkers in elderly patients]. Ruiz Ortega RA; Manzano L; Montero-Pérez-Barquero M Med Clin (Barc); 2014 Mar; 142 Suppl 1():20-5. PubMed ID: 24930079 [TBL] [Abstract][Full Text] [Related]
18. Biomarkers in heart failure: a focus on natriuretic peptides. Eltayeb M; Squire I; Sze S Heart; 2024 May; 110(11):809-818. PubMed ID: 37673654 [TBL] [Abstract][Full Text] [Related]
19. Natriuretic Peptides and the Management of Heart Failure. Kern T; Kedan I; Kimchi A Rev Cardiovasc Med; 2015; 16(2):95-104. PubMed ID: 26198556 [TBL] [Abstract][Full Text] [Related]
20. Changes in natriuretic peptides after acute hospital presentation for heart failure with preserved ejection fraction: A feasible surrogate trial endpoint? A report from the prospective Karen study. Savarese G; Donal E; Hage C; Oger E; Persson H; Daubert JC; Linde C; Lund LH; Int J Cardiol; 2017 Jan; 226():65-70. PubMed ID: 27788392 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]